<p>Abbreviations: BMI, body mass index; OHA, oral hypoglycemic agent.</p>a<p>Means (SE) or percentages are shown;</p>b<p>Mean differences in HbA<sub>1c</sub> values are given compared with metformin monotherapy.</p
<p>BMI indicates body mass index; HCHO, hypercholesterolemia; DM, diabetes mellitus; CAD, coronary a...
<p>Unless otherwise indicated all data are presented as mean ± SD.</p><p>Comparisons are made betwee...
†<p>All subjects were supposed to be on diet and exercise treatment, but 1 subject reported the use ...
<p>Data are percentages, mean ± SD, geometric mean (SD range) or median [inter-quartile range].</p>a...
<p><i>BMI body mass index; HDL high density lipoprotein; IQR interquartile range; LDL low density li...
<p>Of type 2 diabetic subjects, 12 were receiving other hypoglycaemic treatments. SD: Standard Devia...
<p> <i>Abbreviations: BMI, body mass index. HDL, high-density lipoprotein; IDM, incide...
<p>The data are presented as the means (SD) or n (%).<sup>*</sup>Hb<13 g/dL for men and <12 g/dL for...
<p>Abbreviations: TIA transient ischemic attack, SD standard deviation, IQR interquartile range, HbA...
<p>Baseline characteristics of studies comparing glyburide and insulin in the treatment of GDM.</p
<p>Baseline characteristics of study participants by diabetes status (<i>n</i> = 122,402).</p
<p>Results are presented as mean ± SD otherwise indicated. Abbreviations: HbA1c, hemoglobin A1c; BMI...
<p>HbA1c: glycated hemoglobin; VO<sub>2</sub>peak: peak oxygen uptake per kilogram of body weight/fa...
Socio-demographic and baseline characteristics of patients with diabetic (N = 387).</p
<p>Data are expressed as means ± SD, % or median (25th–75th percentiles).</p><p>BMI, body mass index...
<p>BMI indicates body mass index; HCHO, hypercholesterolemia; DM, diabetes mellitus; CAD, coronary a...
<p>Unless otherwise indicated all data are presented as mean ± SD.</p><p>Comparisons are made betwee...
†<p>All subjects were supposed to be on diet and exercise treatment, but 1 subject reported the use ...
<p>Data are percentages, mean ± SD, geometric mean (SD range) or median [inter-quartile range].</p>a...
<p><i>BMI body mass index; HDL high density lipoprotein; IQR interquartile range; LDL low density li...
<p>Of type 2 diabetic subjects, 12 were receiving other hypoglycaemic treatments. SD: Standard Devia...
<p> <i>Abbreviations: BMI, body mass index. HDL, high-density lipoprotein; IDM, incide...
<p>The data are presented as the means (SD) or n (%).<sup>*</sup>Hb<13 g/dL for men and <12 g/dL for...
<p>Abbreviations: TIA transient ischemic attack, SD standard deviation, IQR interquartile range, HbA...
<p>Baseline characteristics of studies comparing glyburide and insulin in the treatment of GDM.</p
<p>Baseline characteristics of study participants by diabetes status (<i>n</i> = 122,402).</p
<p>Results are presented as mean ± SD otherwise indicated. Abbreviations: HbA1c, hemoglobin A1c; BMI...
<p>HbA1c: glycated hemoglobin; VO<sub>2</sub>peak: peak oxygen uptake per kilogram of body weight/fa...
Socio-demographic and baseline characteristics of patients with diabetic (N = 387).</p
<p>Data are expressed as means ± SD, % or median (25th–75th percentiles).</p><p>BMI, body mass index...
<p>BMI indicates body mass index; HCHO, hypercholesterolemia; DM, diabetes mellitus; CAD, coronary a...
<p>Unless otherwise indicated all data are presented as mean ± SD.</p><p>Comparisons are made betwee...
†<p>All subjects were supposed to be on diet and exercise treatment, but 1 subject reported the use ...